Founded
Address
Ajax Therapeutics Inc
275 Madison Ave
39th Floor
New York, NY 10016
United States
Ajax Therapeutics Inc
Cambridge, MA
United States
Phone
Sector
KANDO id: 7269397
Corporate information
Founders
Official name
Ajax Therapeutics Inc
Registration country
Official identities
US CIK 0001780490
Company type
Blood cancer biotech.Overview
Ajax Therapeutics is pursuing uniquely selective approaches to develop novel next generation therapies for myeloproliferative neoplasms (MPNs), including myelofibrosis. By combining the deep cancer and structural biology insights of our founding scientists with the industry’s most advanced computational drug discovery and protein structure platforms, we aim to discover and develop more precisely designed therapies to address the significant unmet needs for patients with MPNs.
Funding rounds
Series C USD 95,000,000
USD 95,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Goldman Sachs Alternative Investments | Initial investment. Led the round. | ||
|
Boxer Capital LLC | Biotech investment firm. | Initial investment. | |
|
Eli Lilly & Co | Initial investment. | ||
|
Point72 Capital Management LLC | Initial investment. | ||
|
RA Capital Management | Initial investment. | ||
|
Vivo Capital LLC | Initial investment. | ||
|
EcoR1 Capital | Biotech-focused investment firm. | Follow-on investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Inning One Ventures | Follow-on investment. | ||
|
Schrödinger Inc | Follow-on investment. |
Investment activity status
Active investor
Team
| Employee | Position | ||
|---|---|---|---|
|
Martin Vogelbaum (founder) |